Cardiomyopathy is a prevalent disease. In the United States, up to a half million people develop a dilated cardiomyopathy every year. Ischemic cardiomyopathy may be present in up to 1% of the population. Because cardiomyopathy tends to be progressive, mortality depends upon the amount of heart pumping function loss; and one goal of therapy is to slow the rate of this loss.
Research on new medical and surgical treatments continues, ranging from new medications, stem cell research, and innovative types of implantable heart assist devices. Ongoing clinical trials for patients with cardiomyopathies are being conducted by the National Institutes of Health.
Medically reviewed by Robert J. Bryg, MD; Board Certified Internal Medicine with subspecialty in Cardiovascular Disease
REFERENCE: Maron, Barry J. MD, Chair; Towbin, Jeffrey A. MD, FAHA; Thiene, Gaetano MD; Antzelevitch, Charles PhD, FAHA; Corrado, Domenico MD, PhD; Arnett, Donna PhD, FAHA; Moss, Arthur J. MD, FAHA; Seidman, Christine E. MD, FAHA; Young, James B. MD, FAHA. "Contemporary Definitions and Classification of the Cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention." Circulation: Volume 113(14)11 April 2006pp 1807-1816.
Medically Reviewed by a Doctor on 11/30/2015
Must Read Articles Related to Cardiomyopathy
Alcohol problems vary in severity from mild to life threatening and affect the individual, the person's family, and society in numerous adverse ways. Signs of a...learn more >>
Congestive Heart Failure
The heart is a pump that works together with the lungs. It pumps blood in two ways. Congestive heart failure is a serious condition, but it can be managed.learn more >>